1st Edition
Handbook of Complementary, Alternative, and Integrative Medicine Education, Practice and Research Volume 5: Disease Focused Efficacy and Safety Profiles: Psychiatric, Infectious, Skin, Hematologic, Oncologic, Urologic and Special Population Diseases/Disorders
Preface
Acknowledgments
Section 1. Psychiatric Disorders
Chapter 1: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Anxiety
Yaser Mohammed Al-Worafi, Nurolaini Kifli, Wafa Mohammed Alseragi, Samar Mohammed Ali, Thamer Faihan Alotaibi and Long Chiau Ming.
Chapter 2: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): sleep disorders
Yaser Mohammed Al-Worafi, Nurolaini Kifli, Wafa Mohammed Alseragi, Samar Mohammed Ali, Thamer Faihan Alotaibi and Long Chiau Ming.
Chapter 3: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Schizophrenia
Yaser Mohammed Al-Worafi, Nurolaini Kifli, Wafa Mohammed Alseragi, Samar Mohammed Ali and Long Chiau Ming.
Chapter 4: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Depressive disorders
Yaser Mohammed Al-Worafi, Nurolaini Kifli, Wafa Mohammed Alsergai, Samar Mohammed Ali, Sulaiman Ali Alaqil and Long Chiau Ming.
Chapter 5: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): bipolar disorders
Yaser Mohammed Al-Worafi, Nurolaini Kifli, Wafa Mohammed Alsergai, Samar Mohammed Ali, Sulaiman Ali Alaqil and Long Chiau Ming.
Section 2. Infectious Diseases
Chapter 6: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Pneumonia.
Yaser Mohammed Al-Worafi, Nurolaini Kifli, Wafa Mohammed Alsergai, Samar Mohammed Ali, Sulaiman Ali Alaqil and Long Chiau Ming.
Chapter 7: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Tuberculosis
Yaser Mohammed Al-Worafi, Nurolaini Kifli, Wafa Mohammed Alsergai, Samar Mohammed Ali, Sulaiman Ali Alaqil and Long Chiau Ming.
Chapter 8: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Central Nervous System Infections
Yaser Mohammed Al-Worafi, Nurolaini Kifli, Wafa Mohammed Alsergai, Samar Mohammed Ali, Sulaiman Ali Alaqil and Long Chiau Ming.
Chapter 9: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Gastrointestinal Infections
Yaser Mohammed Al-Worafi, Nurolaini Kifli, Wafa Mohammed Alsergai, Samar Mohammed Ali, Sulaiman Ali Alaqil and Long Chiau Ming.
Chapter 10: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Wounds/Surgical site infections
Yaser Mohammed Al-Worafi, Nurolaini Kifli, Wafa Mohammed Alsergai, Samar Mohammed Ali, Sulaiman Ali Alaqil and Long Chiau Ming.
Chapter 11: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Endocarditis
Yaser Mohammed Al-Worafi
Chapter 12: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Fungal Infections
Yaser Mohammed Al-Worafi
Chapter 13: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Viral infections
Yaser Mohammed Al-Worafi
Chapter 14: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): COVID
Yaser Mohammed Al-Worafi
Chapter 15: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Malaria
Yaser Mohammed Al-Worafi
Chapter 16: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Amebiasis and Giardiasis
Yaser Mohammed Al-Worafi
Chapter 17: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Dengue fever
Yaser Mohammed Al-Worafi
Chapter 18: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Urinary Tract Infections
Yaser Mohammed Al-Worafi
Chapter 19: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Skin Infections
Yaser Mohammed Al-Worafi
Chapter 20: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Sexually Transmitted Diseases
Yaser Mohammed Al-Worafi
Chapter 21: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Hepatitis
Yaser Mohammed Al-Worafi
Chapter 22: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): HIV
Yaser Mohammed Al-Worafi
Chapter 23: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Cholera
Yaser Mohammed Al-Worafi
Chapter 24: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Mpox (Monkeypox)
Yaser Mohammed Al-Worafi
Section 3. Skin Disorders
Chapter 25: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Acne
Yaser Mohammed Al-Worafi, Ye Wint Oo and Srinivasan Ramamurthy
Chapter 26: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Psoriasis
Yaser Mohammed Al-Worafi
Chapter 27: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Eczema
Yaser Mohammed Al-Worafi
Chapter 28: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Warts
Yaser Mohammed Al-Worafi, Abdullah Ahmed Dhabali, Mohammad Jamshed Siddiqui, Shazia Jamshed, Wafa Mohammed Alseragi and Abdulkareem Mohammed Al-Shami
Section 4. Hematologic Disorders
Chapter 29: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Anemia
Yaser Mohammed Al-Worafi, Abdullah Ahmed Dhabali, Mohammad Jamshed Siddiqui, Abdulkareem Mohammed Al-Shami, Wafa Mohammed Alseragi and Shazia Jamshed.
Chapter 30: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): sickle cell disease
Yaser Mohammed Al-Worafi, Srinivasan Ramamurthy, Ye Wint Oo, Abdulkareem Mohammed Al-Shami and Wafa Mohammed Alseragi.
Section 5. Oncologic Disorders
Chapter 31: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Breast Cancer
Yaser Mohammed Al-Worafi, Samar Mohammed Ali, Srinivasan Ramamurthy, Ye Wint Oo, Apoorva Dev M, Rowaida Jahaz Almutairi, Muhammad Junaid Farrukh, Abdulkareem Mohammed Al-Shami and Wafa Mohammed Alseragi.
Chapter 32: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Colorectal Cancer
Yaser Mohammed Al-Worafi, Srinivasan Ramamurthy, Ye Wint Oo, Muhammad Junaid Farrukh, Abdulkareem Mohammed Al-Shami and Wafa Mohammed Alseragi.
Chapter 33: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Lung Cancer
Yaser Mohammed Al-Worafi, Abdulsalam Halboup, Nabeel Ayappali Kalluvalappil and Wafa Mohammed Alseragi.
Chapter 34: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): prostate Cancer
Yaser Mohammed Al-Worafi, Abdulsalam Halboup, Nabeel Ayappali Kalluvalappil and Wafa Mohammed Alseragi.
Chapter 35: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Ovarian Cancer
Yaser Mohammed Al-Worafi
Chapter 36: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Lymphomas Cancer
Yaser Mohammed Al-Worafi
Chapter 37: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Leukemia
Yaser Mohammed Al-Worafi, Samar Mohammed Ali, Turki Hamad Almutairi, Khairi Wazien Umar and Wafa Mohammed Alseragi.
Chapter 38: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Skin Cancer
Yaser Mohammed Al-Worafi
Chapter 39: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Liver Cancer
Yaser Mohammed Al-Worafi
Section 6. Urologic Disorders
Chapter 40: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Erectile Dysfunction
Yaser Mohammed Al-Worafi
Chapter 41: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Benign Prostatic Hyperplasia
Yaser Mohammed Al-Worafi
Chapter 42: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Urinary Incontinence
Yaser Mohammed Al-Worafi
Section 7. Special Population, services and Care
Chapter 43: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Geriatrics
Yaser Mohammed Al-Worafi
Chapter 44: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Paediatrics
Yaser Mohammed Al-Worafi, Samar Mohammed Ali, Srinivasan Ramamurthy, Ye Wint Oo, Yasir Sulaiman Alhassan and Wafa Mohammed Alseragi.
Chapter 45: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Pregnancy
Yaser Mohammed Al-Worafi
Chapter 46: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Lactation
Yaser Mohammed Al-Worafi
Chapter 47: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Malnutrition
Yaser Mohammed Al-Worafi
Chapter 48: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Weight management
Yaser Mohammed Al-Worafi
Chapter 49: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Smoking cessation
Yaser Mohammed Al-Worafi
Chapter 50: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Skin Care and beauty
Yaser Mohammed Al-Worafi
Chapter 51: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Hair Care
Yaser Mohammed Al-Worafi
Chapter 52: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Sports and Athletes
Yaser Mohammed Al-Worafi
Biography
Yaser Mohammed Al-Worafi, PhD is a Professor of Clinical Pharmacy at College of Pharmacy, University of Science and Technology of Fujairah, UAE (Previously known as Ajman University) and University of Science and Technology, Yemen. He graduated with a bachelor's degree in Pharmacy (BPharm) from Sana’a University, Yemen and earned Master's and PhD degrees in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia. He has more than 20 years’ experience in education, practice and research in Yemen, Saudi Arabia, United Arab Emirates and Malaysia. He has held various academic and professional positions including: Head of Clinical Pharmacy/Pharmacy Practice Department; Head of Teaching & Learning Committee, Head of Training Committee and other committees. He has authored over 100 peer-reviewed papers in international journals, as well as book chapters. He has edited many books, one book published by Elsevier in June, 2020 and one handbook accepted by Springer. Prof. Al-Worafi has supervised/co-supervised many PhD, Master's, PharmD and B-Pharm students. He is a reviewer for eight recognized international peer-reviewed journals. Prof. Al-Worafi prepared and wrote the first draft of Master of Clinical Pharmacy Program and PharmD Internship manual. He was a member of the founding committee of the integrated PharmD curriculum at Unizah College of Pharmacy.
